tiprankstipranks
Trending News
More News >
Spruce Biosciences (SPRB)
NASDAQ:SPRB
US Market

Spruce Biosciences (SPRB) Financial Statements

Compare
450 Followers

Spruce Biosciences Financial Overview

Spruce Biosciences's market cap is currently $80.13M. The company's EPS TTM is $-8.73; its P/E ratio is -1.71; Spruce Biosciences is scheduled to report earnings on March 9, 2026, and the estimated EPS forecast is $-8.81. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 4.91M$ 10.09M$ 0.00$ 0.00
Gross Profit$ -21.00K$ 4.91M$ 10.09M$ 0.00$ 0.00
Operating Income$ -36.51M$ -56.15M$ -51.99M$ -47.28M$ -42.07M
EBITDA$ -36.51M$ -52.68M$ -47.37M$ -45.69M$ -41.88M
Net Income$ -38.97M$ -53.04M$ -47.92M$ -46.18M$ -42.29M
Balance Sheet
Cash & Short-Term Investments$ 48.91M$ 38.75M$ 96.34M$ 79.08M$ 88.97M
Total Assets$ 53.02M$ 45.21M$ 103.95M$ 85.65M$ 126.49M
Total Debt$ 419.00K$ 2.77M$ 4.61M$ 6.32M$ 6.53M
Net Debt$ -48.49M$ -35.99M$ -91.73M$ -18.17M$ -36.22M
Total Liabilities$ 10.51M$ 16.39M$ 27.44M$ 17.16M$ 15.12M
Stockholders' Equity$ 42.52M$ 28.82M$ 76.51M$ 68.49M$ 111.37M
Cash Flow
Free Cash Flow$ -33.33M$ -55.96M$ -33.28M$ -41.69M$ -35.97M
Operating Cash Flow$ -33.33M$ -55.96M$ -33.27M$ -41.68M$ -35.88M
Investing Cash Flow$ 0.00$ 0.00$ 55.78M$ 23.69M$ -79.17M
Financing Cash Flow$ 43.48M$ -1.62M$ 49.14M$ -241.00K$ 643.00K
Currency in USD

Spruce Biosciences Earnings and Revenue History

Spruce Biosciences Debt to Assets

Spruce Biosciences Cash Flow

Spruce Biosciences Forecast EPS vs Actual EPS